Effect of Rifampin on the Pharmacokinetics of Ertugliflozin in Healthy Subjects

Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

Andrew S. Levey, Josef Coresh, Tom Greene et al. · Annals of Internal Medicine · 2006 · 5.8K citations

Medicine, Biostatistics, Nephrology +17

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial

Richard E. Pratley, Roy Eldor, Annaswamy Raji et al. · Diabetes Obesity and Metabolism · 2017 · 164 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The <scp>VERTIS SITA2</scp> placebo‐controlled randomized study

Samuel Dagogo‐Jack, Jie Liu, Roy Eldor et al. · Diabetes Obesity and Metabolism · 2017 · 160 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug–Drug Interaction Trial Design

Marc L. Reitman, Xiaoyan Chu, Xiaoxin Cai et al. · Clinical Pharmacology & Therapeutics · 2010 · 157 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone

Steven G. Terra, Kristen Focht, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2017 · 145 citations

Medicine, Pharmacology, Pharmacotherapy +17